A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary …

AS MacDonald - Transplantation, 2001 - journals.lww.com
Background. Despite the various immunosuppressive regimens presently in use, acute
rejection in the early postoperative period continues to occur in 20 to 40% of renal transplant …

A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease

…, N Williams, AS MacDonald… - … England Journal of …, 1989 - Mass Medical Soc
We randomly assigned 71 patients with active chronic Crohn's disease who were resistant
to or intolerant of corticosteroids to treatment with oral cyclosporine (5 to 7.5 mg per kilogram …

Sirolimus-tacrolimus combination immunosuppression

…, K Peltekian, J Domingues, K Mahalati, AS MacDonald - The Lancet, 2000 - thelancet.com
Summary A series of 32 recipients of liver, kidney, or pancreas transplants who were treated
with sirolimus and low-dose tacrolimus experienced a low rate of rejection and excellent …

Is routine ureteric stenting needed in kidney transplantation? A randomized trial

…, CM Clase, K Mahalati, AS MacDonald… - …, 2000 - journals.lww.com
Background. Whether routine ureteric stenting in low-urological-risk patients reduces the risk
of urological complications in kidney transplantation is not established. Methods. Eligible …

Calcified subcutaneous arterioles with infarcts of the subcutis and skin (“calciphylaxis”) in chronic renal failure

…, DJ Hirsch, GA Klassen, AS MacDonald - American journal of …, 2000 - Elsevier
Patients with chronic renal failure (CRF) are at increased risk for pathological calcifications
because of increased serum calcium-phosphorus products. A minority, including those …

[PDF][PDF] Orthotopic liver transplantation using low‐dose tacrolimus and sirolimus

…, DA Malatjalian, S Colohan, S MacDonald… - Liver …, 2001 - Wiley Online Library
Although sirolimus (SRL) binds the immunophilin FK506‐binding protein‐12 (FKBP‐12)
with greater avidity than tacrolimus (TAC), animal studies have shown that SRL and TAC act …

The incidence and impact of early rejection episodes on graft outcome in recipients of first cadaver kidney transplants

AC GULANIKAR, AS MACDONALD… - …, 1992 - journals.lww.com
THE INCIDENCE AND IMPACT OF EARLY REJECTION EPISODES ON GRAF... :
Transplantation THE INCIDENCE AND IMPACT OF EARLY REJECTION EPISODES ON …

A clinical pharmacokinetic study of tacrolimus and sirolimus combination immunosuppression comparing simultaneous to separated administration

…, KM Peltekian, A Fraser, AS MacDonald - Therapeutic drug …, 2002 - journals.lww.com
The pharmacokinetic (PK) interaction between tacrolimus (TAC) and sirolimus (SRL), similarly
structured immunosuppressive compounds that share binding proteins, is unknown. The …

Conversion to rapamycin immunosuppression in renal transplant recipients: report of an initial Experience1

…, B Kiberd, VC McAlister, AS MacDonald - …, 2000 - journals.lww.com
Background. The aim of thisstudy is to evaluate the effects of RAPA conversion in patients
undergoing cyclosporine (CsA) or tacrolimus (Tac) toxicity. Methods. Twenty renal transplant …

The effect of dose of thoracic irradiation on recurrence in patients with limited stage small cell lung cancer. Initial results of a Canadian Multicenter Randomized Trial

…, DG Payne, WK Evans, R Feld, AS Macdonald… - International Journal of …, 1988 - Elsevier
Patients with limited stage small cell lung cancer were initially randomized to receive either
three courses of Cyclophosphamide, Adriamycin, and Vincristine (CAV) followed by three …